Houseofcards = 13d groupie Soft bashing and as
Post# of 148166
Soft bashing and asking questions to bring doubt… as you already suspected by inquiring about the IHUB alias… but the other like me that don’t always pick up on the small soft bashing… this is who this is… a groupie.
We have enough money to get to the end of the year as Super Nader said. BTD’s are possible times 4 indications and things are looking really good in our immediate future.
Reminder*** would not of happened if we focused on one indication at a time as the 13d group wants to do. They would of stopped all trials and just focused on the HIV BLA until completion. Not the type of management that we want. Turtle slow and going no where. We have the right management to become the largest platform drug ever. 65+ indications. If we get half approved we will exceed Truvada’s measly 31 indications. Oh the thought of us growing into our own Biggest ever Pharmaceutical Company… you won’t get that with the 13d group. They more than likely will sell Cytodyn to the lowest bidder. It’s how their BOD operates… they were probably brought in by a big Pharma to lower our sale price but they were just a little to late with all these possible approvals. Vote current management for our investor wealth! This is the right choice for future wealth…